Helping protect medical professionals

Sandia researchers work with NM small businesses to test new respirator materials
Sandia National Laboratories

Newswise — ALBUQUERQUE, N.M. — A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

“I can almost assure you that no one else in the country is making respirators the way we’re making them,” said Dave Mayberry, technical lead for Marpac, Sierra Peaks and Sew-EZ, the companies that worked with Sandia on materials testing. “We didn’t want to research the same materials already used in the typical N95 supply chain due to availability issues, so we looked into other materials we could get ahold of that seemed most likely to meet the filtration requirements.”

Marpac, Sierra Peaks and Sew-EZ were matched with Sandia scientists through the New Mexico Small Business Assistance program that pairs Sandia and Los Alamos national laboratories with companies seeking help to solve technical problems. Sandia worked on a project with each company.

“It’s been very satisfying to see NMSBA, a state program, help New Mexico businesses address COVID-19 issues,” said Jackie Kerby Moore, manager of technology and economic development at Sandia. “It was also rewarding to see the Sandia team jump on the opportunity to help these three businesses with their respirators.”

Marpac specializes in manufacturing medical tube securement devices and works closely with engineering and manufacturing companies Sierra Peaks and Sew-EZ.

Mayberry reached out to Sandia after receiving an inquiry from a local hospital to see if the company could help address the potential shortage of N95 respirators. Certified N95 respirators are worn like masks and protect users from 95% of airborne particles and liquid contamination.

Sandia has the equipment and expertise to help, and within a few days after Marpac reached out, a team of scientists began working on the challenging task of modifying systems to make sure samples were tested properly.

Sandia principal investigator Michael Omana said the team modified aerosol and filtration systems typically used for nuclear nonproliferation work. They had to reduce the systems’ airflow significantly to mimic the rate that humans breathe. They also modified existing test boxes to quickly mount and seal the samples inside prior to running them through the testbed.

“We were tapped about the first project with Marpac on a Thursday and drafted the scope of work and contract by Friday,” Omana said. “By Monday or Tuesday, we had finished all system modifications. Initial testing of the first set of materials was completed by the end of the week, and data was provided to Marpac.”

Initial test materials underperformed, with the best sample coming within 10% of the desired filtration levels. Within a couple of weeks, the researchers started seeing promising results from new material compositions. Creativity in combining materials resulted in samples with protection levels comparable to N95 respirators.

Marpac manufactured 500 N95-like respirators using the materials Sandia tested, and Mayberry said they passed fit tests at a local hospital. They’re also looking into additional medical facilities that could use the product.

“We feel fortunate that the local hospital provider came to us after seeing our capabilities,” Mayberry said. “This definitely stretched us out of our comfort zone, and certainly without the technical support from Sandia Labs, this would have been hard to validate all the types of materials that would be likely constructed into a respirator.”

Working quickly was critical for the projects, Sandia distinguished technologist Dora Wiemann said, and the team put in long hours — including on weekends.

The projects with each company built upon each other. For the first project with Marpac, researchers tested sheets of composite materials provided by the company in the large, modified filtration system.

For the second project with Sierra Peaks, additional test-box modifications enabled the scientists to mount and seal samples cut in respirator geometries, and to complete comparison studies against certified N95 respirators.

The third project with Sew-EZ, which is ongoing, involves further sample testing using the filtration system and an additional commercial-off-the-shelf system, which is typically used by industry to certify products like N95 respirators.

“Sandia is not a certification lab, but the joint use of the systems enabled us to provide data that may be compared against products which have been certified through traditional avenues,” Omana said. “This data will help the company if it chooses to seek certification of its product through the proper organizations.”

Omana and a couple of other researchers test the materials in the lab, then forward data to be processed into quantitative results. The timeline on all projects has been tight, but the researchers said promising tests have been rewarding, especially because the result has the potential to help people during a time of crisis.

“I’m glad to be in the position I am so that I can help with this really big issue with characterizing materials that can be used for N95 replacements,”  Wiemann said. “By the end of the initial modifications and testing, we were a very close-knit team, solving an important problem. It was exhausting and exhilarating.”

Filters close

Showing results

110 of 3395
Newswise: Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
22-Sep-2020 4:00 PM EDT
Historical Racial & Ethnic Health Inequities Account for Disproportionate COVID-19 Impact
American Thoracic Society (ATS)

A new Viewpoint piece published online in the Annals of the American Thoracic Society examines the ways in which COVID-19 disproportionately impacts historically disadvantaged communities of color in the United States, and how baseline inequalities in our health system are amplified by the pandemic. The authors also discuss potential solutions.

Released: 24-Sep-2020 5:05 PM EDT
In-person college instruction leading to thousands of COVID-19 cases per day in US
University of Washington

Reopening university and college campuses with primarily in-person instruction is associated with a significant increase in cases of COVID-19 in the counties where the schools are located.

Newswise: Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body
Released: 24-Sep-2020 3:25 PM EDT
Some Severe COVID-19 Cases Linked to Genetic Mutations or Antibodies that Attack the Body
Howard Hughes Medical Institute (HHMI)

Two new studies offer an explanation for why COVID-19 cases can be so variable. A subset of patients has mutations in key immunity genes; other patients have auto-antibodies that target the same components of the immune system. Both circumstances could contribute to severe forms of the disease.

access_time Embargo lifts in 2 days
Embargo will expire: 25-Sep-2020 6:30 PM EDT Released to reporters: 24-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Sep-2020 6:30 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

17-Sep-2020 1:15 PM EDT
Accuracy of commercial antibody kits for SARS-CoV-2 varies widely

There is wide variation in the performance of commercial kits for detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published September 24 in the open-access journal PLOS Pathogens by Jonathan Edgeworth and Blair Merrick of Guy’s and St Thomas’ NHS Foundation Trust, Suzanne Pickering and Katie Doores of King's College London, and colleagues. As noted by the authors, the rigorous comparison of antibody testing platforms will inform the deployment of point-of-care technologies in healthcare settings and their use in monitoring SARS-CoV-2 infections.

24-Sep-2020 9:25 AM EDT
Loneliness levels high during COVID-19 lockdown
Newswise Review

During the initial phase of COVID-19 lockdown, rates of loneliness among people in the UK were high and were associated with a number of social and health factors, according to a new study published this week in the open-access journal PLOS ONE by Jenny Groarke of Queen’s University Belfast, UK, and colleagues.

Newswise: Genetic, immunological abnormalities in Type I interferon pathway are risk factors for severe COVID-19
24-Sep-2020 12:35 PM EDT
Genetic, immunological abnormalities in Type I interferon pathway are risk factors for severe COVID-19
Uniformed Services University of the Health Sciences (USU)

Individuals with severe forms of COVID-19 disease can present with compromised type I interferon (IFN) responses based on their genetics, according to results published in two papers today in the journal Science. Type I IFN responses are critical for protecting cells and the body from more severe disease after acute viral infection.

Newswise: Talking Alone: Researchers Use Artificial Intelligence Tools to Predict Loneliness
Released: 24-Sep-2020 1:45 PM EDT
Talking Alone: Researchers Use Artificial Intelligence Tools to Predict Loneliness
University of California San Diego Health

A team led by researchers at University of California San Diego School of Medicine has used artificial intelligence technologies to analyze natural language patterns to discern degrees of loneliness in older adults.

Showing results

110 of 3395